EUVIMEDEUVIMED entdecken
Crossref

A Case of Pure Red Cell Aplasia After Immune Checkpoint Inhibitor Therapy for Squamous Cell Lung Cancer

Toshihiro Kuroki, Hajime Kikuchi, Yukika Odani, Masafumi Ikezawa, Yumi Morinaga, Yu Yamashita, Miki Sato, Kei Takamura, Kentaro Wakasa, Keisuke Kikuchi

Haigan · 20.04.2026 · 66 (2) · 97-102

DOI: 10.2482/haigan.66.97 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Haigan, erschienen am 20.04.2026. Verfasst von Toshihiro Kuroki und 9 weiteren Autor:innen. Die Arbeit nennt 8 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Kuroki, T., Kikuchi, H., Odani, Y., Ikezawa, M., Morinaga, Y., Yamashita, Y., Sato, M., Takamura, K., Wakasa, K., & Kikuchi, K. (2026). A Case of Pure Red Cell Aplasia After Immune Checkpoint Inhibitor Therapy for Squamous Cell Lung Cancer. Haigan, 66(2), 97-102. https://doi.org/10.2482/haigan.66.97

Vancouver

Kuroki T, Kikuchi H, Odani Y, Ikezawa M, Morinaga Y, Yamashita Y, et al. A Case of Pure Red Cell Aplasia After Immune Checkpoint Inhibitor Therapy for Squamous Cell Lung Cancer. Haigan. 2026;66(2):97-102. doi:10.2482/haigan.66.97

BibTeX
@article{Kuroki2026,
  author = {Kuroki, Toshihiro and Kikuchi, Hajime and Odani, Yukika and Ikezawa, Masafumi and Morinaga, Yumi and Yamashita, Yu and Sato, Miki and Takamura, Kei and Wakasa, Kentaro and Kikuchi, Keisuke},
  title = {A Case of Pure Red Cell Aplasia After Immune Checkpoint Inhibitor Therapy for Squamous Cell Lung Cancer},
  journal = {Haigan},
  year = {2026},
  volume = {66},
  number = {2},
  pages = {97--102},
  doi = {10.2482/haigan.66.97}
}
Kostenlos starten →